Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM
Total 13F shares
128,978
Share change
-8,152,062
Total reported value
$40,918
Price per share
$0.30
Number of holders
3
Value change
-$2,370,438
Number of buys
1
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Medicenna Therapeutics Corp. - COM (MDNAF) as of Q4 2023

As of 31 Dec 2023, Medicenna Therapeutics Corp. - COM (MDNAF) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 128,978 shares. The largest 3 holders included Rathbones Group PLC, Newman Dignan & Sheerar, Inc., and RAYMOND JAMES & ASSOCIATES. This page lists 3 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.